Role of high mobility group box 1 (HMGB1) in wound healing

Journal of Surgical Research

Volumn 176, Issue 1, 2012, Pages 343-347

  Zhang, Qiang ^a   O'Hearn, Sean ^a   Kavalukas, Sandra L ^a   Barbul, Adrian ^b  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

collagen; ethyl pyruvate; fibroblast; high mobility group box 1 protein; rat; receptor for advanced glycation end products; wound

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ANTIBODY; COLLAGEN; HIGH MOBILITY GROUP B1 PROTEIN; PYRUVIC ACID; PYRUVIC ACID ETHYL ESTER; UNCLASSIFIED DRUG;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FIBROBLAST; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; TENSILE STRENGTH; WOUND HEALING;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; FIBROBLASTS; GLYCOSYLATION END PRODUCTS, ADVANCED; HMGB1 PROTEIN; INFLAMMATION; MALE; MODELS, ANIMAL; PYRUVATES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; WOUND HEALING;

EID: 84862016222     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.06.069     Document Type: Article

References (39)

1. J.O. Thomas HMG1 and 2: Architectural DNA-binding proteins Biochem Soc Trans 29 2001 395
2. D. Landsman, and M. Bustin Assessment of the transcriptional activation potential of the HMG chromosomal proteins Mol Cell Biol 11 1991 4483
3. H. Nakamura, Y. Izumoto, and H. Kambe Molecular cloning of complementary DNA for a novel human hepatoma-derived growth factor. Its homology with high mobility group-1 protein J Biol Chem 269 1994 25143
4. H. Wang, H. Yang, and C.J. Czura HMGB1 as a late mediator of lethal systemic inflammation Am J Respir Crit Care Med 164 2001 1768
5. P. Scaffidi, T. Misteli, and M.E. Bianchi Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 2002 191
6. P. Rovere-Querini, A. Capobianco, and P. Scaffidi HMGB1 is an endogenous immune adjuvant released by necrotic cells EMBO Rep 5 2004 825
7. R. Pullerits, I. Jonsson, and M. Verdrengh High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis Arthritis Rheum 48 2003 1693
8. X.X. Yan, L. Lu, and W.H. Peng Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients Atherosclerosis 205 2009 544
9. K. Inoue, K. Kawahara, and K.K. Biswas HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques Cardiovasc Pathol 16 2007 136
10. H. Wang, O. Bloom, and M. Zhang HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248
11. S.F. Yan, R. Ramasamy, and L.G. Bucciarelli RAGE and its ligands: A lasting memory in diabetic complications? Diab Vasc Dis Res 1 2004 10
12. J.S. Park, D. Svetkauskaite, and Q. He Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J Biol Chem 279 2004 7370
13. M. Yu, H. Wang, and A. Ding HMGB1 signals through toll-like receptor (TLR) 4 and TLR2 Shock 26 2006 174
14. H.C. Volz, Z. Kaya, and H.A. Katus The role of HMGB1/RAGE in inflammatory cardiomyopathy Semin Thromb Hemost 36 2010 185
15. A. Soro-Paavonen, A.M. Watson, and J. Li Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes Diabetes 57 2008 2461
16. R. Kokkola, A. Andersson, and G. Mullins RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages Scand J Immunol 6 2005 11
17. S. Mitola, M. Belleri, and C. Urbinati Cutting edge: Extracellular high mobility group box-1 protein is a proangiogenic cytokine J Immunol 176 2006 12
18. C. Cheng, K. Tsuneyama, and R. Kominami Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs Mod Pathol 18 2005 1385
19. C. Lohwasser, D. Neureiter, and B. Weigle The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-α J Invest Dermatol 126 2006 291
20. J. Molinari, E. Ruszova, and V. Velebny Effect of advanced glycation end products on gene expression profiles of human dermal fibroblasts Biogerontology 9 2008 177
21. F. Zhang, K.C. Kent, and D. Yamanouchi Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm Ann Surg 250 2009 416
22. Q. Wang, Q. Ding, and Y. Zhou Ethyl pyruvate attenuates spinal cord ischemic injury with a wide therapeutic window through inhibiting high-mobility group box 1 release in rabbits Anesthesiology 110 2009 1279
23. A. Barbul, G. Rettura, and S.M. Levenson Wound healing and thymotropic effects of arginine: A pituitary mechanism of action Am J Clin Nutr 37 1983 786
24. E. Seifter, G. Rettura, and A. Barbul Arginine: An essential amino acid for injured rats Surgery 84 1978 224
25. H.P. Shi, S.M. Wang, and G.X. Zhang Supplemental L-arginine enhances wound healing following trauma/hemorrhagic shock Wound Repair Regen 15 2007 66
26. M.C. Regan, S.J. Kirk, and H.L. Wasserkrug The wound environment as a regulator of fibroblast phenotype J Surg Res 50 1991 442
27. H. Weichert, I. Blechschmidt, and S. Schroder The MTT-assay as a rapid test for cell proliferation and cell killing: Application to human peripheral blood lymphocytes (PBL) Allerg Immunol (Leipz) 37 1991 139
28. K. Zimmermann, D. Volkel, and S. Pable Native versus recombinant high-mobility group B1 proteins: Functional activity in vitro Inflammation 28 2004 221
29. S. Straino, C.A. Di, and A. Mangoni High-mobility group box 1 protein in human and murine skin: Involvement in wound healing J Invest Dermatol 128 2008 1545
30. U. Andersson, H. Wang, and K. Palmblad High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes J Exp Med 192 2000 565
31. G. Chen, M.F. Ward, and A.E. Sama Extracellular HMGB1 as a proinflammatory cytokine J Interferon Cytokine Res 24 2004 329
32. O.M. Alvarez, K.D. Levendorf, and R.V. Smerbeck Effect of topically applied steroidal and nonsteroidal anti-inflammatory agents on skin repair and regeneration Fed Proc 43 1984 2793
33. R.H. Lee, D.T. Efron, and U. Tantry Inhibition of tumor necrosis factor-α attenuates wound breaking strength in rats Wound Repair Regeneration 8 2000 547
34. I. Goren, E. Muller, and D. Schiefelbein Systemic anti-TNF-α treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages J Invest Dermatol 127 2007 2259
35. L. Ulloa, M. Ochani, and H. Yang Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation Proc Natl Acad Sci U.S.A 99 2002 12351
36. M.C. Regan, S.J. Kirk, and H.L. Wasserkrug The wound environment as a regulator of fibroblast phenotype J Surgical Res 50 1991 442
37. P.L. Liu, J.R. Tsai, and J.J. Hwang HMGB1-Mediated MMP-9 Expression in non-small cell lung cancer contributes to tumor cell invasiveness Am J Respir Cell Mol Biol 43 2010 530
38. M. Takada, K. Hirata, and T. Ajiki Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells Hepatogastroenterology 51 2004 928
39. O. Hori, J. Brett, and T. Slattery The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system J Biol Chem 270 1995 25752